Who invested in Viage Therapeutics?
Viage Therapeutics's investors include ANRI and Kyoto University Innovation Capital Co., Ltd.

United States · Seed startup
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2022, from 1 source
From Viage Therapeutics's own website: 2 on the team.
Viage Therapeutics's investors include ANRI and Kyoto University Innovation Capital Co., Ltd.
Viage Therapeutics has raised $10M across 1 round since 2022.
Viage Therapeutics's most recent round was a Seed of $10M in Jan 2022.
Its most recent round, $10M in Jan 2022, is also its largest on record.
Viage Therapeutics's first round on record, in Jan 2022, was backed by ANRI and Kyoto University Innovation Capital Co., Ltd.
Viage Therapeutics's latest named round is a Seed, in Jan 2022.
Viage Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.